Viatris - Company Profile

All the data and insights you need on Viatris in one report.

• Save hours of research time and resources with our up-to-date Viatris Strategy Report
• Understand Viatris's position in the market, performance, and strategic initiatives
• Gain competitive edge and increase your chances of success

Viatris Company Profile Overview

Viatris is a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer. It aims to provide access to high-quality medicines, with a focus on ensuring that patients around the world can have affordable and reliable healthcare solutions. With a legacy of over 80 years in the pharmaceutical industry, Viatris operates in more than 165 countries and is committed to empowering people worldwide to live healthier lives.

Core Products and Services

Generic Pharmaceuticals

Cardiovascular
Central Nervous System
Infectious Diseases
Oncology

Over-the-Counter Products

Allergy Relief
Pain Relief
Digestive Health

Biologics

Insulin
Monoclonal Antibodies

Healthcare Solutions

Patient Assistance Programs
Access Solutions

Service Categories

Category	Services Offered
Pharmaceuticals	Manufacturing and distribution of generic and branded medications.
Patient Support	Programs that assist patients in accessing medications and understanding their treatment options.
Research and Development	Innovative solutions to meet unmet medical needs through continuous research.

Business Model

Viatris operates on a diversified business model that combines proprietary innovation with the manufacturing and distribution of generic drugs globally. The company focuses on affordability, accessibility, and quality of medications while engaging in partnerships that enhance patient experiences.

Product sales from generic drugs
Branded medication sales
Collaboration and licensing agreements
Patient access programs

Viatris is dedicated to tackling global health challenges and adapting to changing market conditions to sustain growth.